Cargando…

Natural course of tricuspid regurgitation and prognostic implications

OBJECTIVE: Functional tricuspid regurgitation (TR) is a frequent finding in echocardiography. Literature suggests significant TR is associated with poor prognosis. Still, data remain limited. This study aimed to evaluate long-term prognostic implications in patients with TR. METHODS: In this observa...

Descripción completa

Detalles Bibliográficos
Autores principales: Bannehr, Marwin, Edlinger, Christoph Roland, Kahn, Ulrike, Liebchen, Josephin, Okamoto, Maki, Hähnel, Valentin, Dworok, Victoria, Schipmann, Fabian, Kücken, Tanja, Bramlage, Karin, Bramlage, Peter, Haase-Fielitz, Anja, Butter, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875290/
https://www.ncbi.nlm.nih.gov/pubmed/33563777
http://dx.doi.org/10.1136/openhrt-2020-001529
_version_ 1783649748031373312
author Bannehr, Marwin
Edlinger, Christoph Roland
Kahn, Ulrike
Liebchen, Josephin
Okamoto, Maki
Hähnel, Valentin
Dworok, Victoria
Schipmann, Fabian
Kücken, Tanja
Bramlage, Karin
Bramlage, Peter
Haase-Fielitz, Anja
Butter, Christian
author_facet Bannehr, Marwin
Edlinger, Christoph Roland
Kahn, Ulrike
Liebchen, Josephin
Okamoto, Maki
Hähnel, Valentin
Dworok, Victoria
Schipmann, Fabian
Kücken, Tanja
Bramlage, Karin
Bramlage, Peter
Haase-Fielitz, Anja
Butter, Christian
author_sort Bannehr, Marwin
collection PubMed
description OBJECTIVE: Functional tricuspid regurgitation (TR) is a frequent finding in echocardiography. Literature suggests significant TR is associated with poor prognosis. Still, data remain limited. This study aimed to evaluate long-term prognostic implications in patients with TR. METHODS: In this observational cohort study, data from 1650 consecutive patients were analysed. Primary endpoint was all-cause mortality. Mean follow-up time was 1090 days. TR grades at baseline and follow-up were compared. Survival analyses were performed to identify prognostic factors. RESULTS: At baseline, 14.1% patients showed no, 63.8% mild, 17.4% moderate and 4.7% severe TR. 359 patients (21.8%) died within the study period. TR at baseline was associated with excess mortality. Moderate and severe TR were of prognostic implication in all subgroups irrespective of systolic pulmonary artery pressure (sPAP) (</≥40 mm Hg) and left ventricular ejection fraction (LV-EF) (</≥50%). Survival was worst in patients with moderate and severe TR and concomitant elevated sPAP or reduced LV-EF at 1 and 3 years, respectively (p<0.001; p<0.001). In a multivariate model, including cardiac and non-cardiac risk factors, moderate and severe TR, sPAP and impaired right ventricular (RV) function were independent predictors for survival (HR 1.89, CI 1.07 to 3.36, p=0.029; HR 2.93, CI 1.57 to 5.49, p=0.001; HR 1.44, CI 1.25 to 1.65, p<0.001; HR 1.43, CI 1.14 to 1.79, p=0.002). Overall progression of TR on follow-up was 28.4%. Patients with TR progression showed significantly worse survival (HR 1.44, CI 1.11 to 1.81; p=0.006). CONCLUSION: While TR progressed over time, it was associated with impaired long-term survival. TR grade, RV dysfunction, sPAP and TR progression were independent predictors for survival.
format Online
Article
Text
id pubmed-7875290
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-78752902021-02-18 Natural course of tricuspid regurgitation and prognostic implications Bannehr, Marwin Edlinger, Christoph Roland Kahn, Ulrike Liebchen, Josephin Okamoto, Maki Hähnel, Valentin Dworok, Victoria Schipmann, Fabian Kücken, Tanja Bramlage, Karin Bramlage, Peter Haase-Fielitz, Anja Butter, Christian Open Heart Valvular Heart Disease OBJECTIVE: Functional tricuspid regurgitation (TR) is a frequent finding in echocardiography. Literature suggests significant TR is associated with poor prognosis. Still, data remain limited. This study aimed to evaluate long-term prognostic implications in patients with TR. METHODS: In this observational cohort study, data from 1650 consecutive patients were analysed. Primary endpoint was all-cause mortality. Mean follow-up time was 1090 days. TR grades at baseline and follow-up were compared. Survival analyses were performed to identify prognostic factors. RESULTS: At baseline, 14.1% patients showed no, 63.8% mild, 17.4% moderate and 4.7% severe TR. 359 patients (21.8%) died within the study period. TR at baseline was associated with excess mortality. Moderate and severe TR were of prognostic implication in all subgroups irrespective of systolic pulmonary artery pressure (sPAP) (</≥40 mm Hg) and left ventricular ejection fraction (LV-EF) (</≥50%). Survival was worst in patients with moderate and severe TR and concomitant elevated sPAP or reduced LV-EF at 1 and 3 years, respectively (p<0.001; p<0.001). In a multivariate model, including cardiac and non-cardiac risk factors, moderate and severe TR, sPAP and impaired right ventricular (RV) function were independent predictors for survival (HR 1.89, CI 1.07 to 3.36, p=0.029; HR 2.93, CI 1.57 to 5.49, p=0.001; HR 1.44, CI 1.25 to 1.65, p<0.001; HR 1.43, CI 1.14 to 1.79, p=0.002). Overall progression of TR on follow-up was 28.4%. Patients with TR progression showed significantly worse survival (HR 1.44, CI 1.11 to 1.81; p=0.006). CONCLUSION: While TR progressed over time, it was associated with impaired long-term survival. TR grade, RV dysfunction, sPAP and TR progression were independent predictors for survival. BMJ Publishing Group 2021-02-09 /pmc/articles/PMC7875290/ /pubmed/33563777 http://dx.doi.org/10.1136/openhrt-2020-001529 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Valvular Heart Disease
Bannehr, Marwin
Edlinger, Christoph Roland
Kahn, Ulrike
Liebchen, Josephin
Okamoto, Maki
Hähnel, Valentin
Dworok, Victoria
Schipmann, Fabian
Kücken, Tanja
Bramlage, Karin
Bramlage, Peter
Haase-Fielitz, Anja
Butter, Christian
Natural course of tricuspid regurgitation and prognostic implications
title Natural course of tricuspid regurgitation and prognostic implications
title_full Natural course of tricuspid regurgitation and prognostic implications
title_fullStr Natural course of tricuspid regurgitation and prognostic implications
title_full_unstemmed Natural course of tricuspid regurgitation and prognostic implications
title_short Natural course of tricuspid regurgitation and prognostic implications
title_sort natural course of tricuspid regurgitation and prognostic implications
topic Valvular Heart Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875290/
https://www.ncbi.nlm.nih.gov/pubmed/33563777
http://dx.doi.org/10.1136/openhrt-2020-001529
work_keys_str_mv AT bannehrmarwin naturalcourseoftricuspidregurgitationandprognosticimplications
AT edlingerchristophroland naturalcourseoftricuspidregurgitationandprognosticimplications
AT kahnulrike naturalcourseoftricuspidregurgitationandprognosticimplications
AT liebchenjosephin naturalcourseoftricuspidregurgitationandprognosticimplications
AT okamotomaki naturalcourseoftricuspidregurgitationandprognosticimplications
AT hahnelvalentin naturalcourseoftricuspidregurgitationandprognosticimplications
AT dworokvictoria naturalcourseoftricuspidregurgitationandprognosticimplications
AT schipmannfabian naturalcourseoftricuspidregurgitationandprognosticimplications
AT kuckentanja naturalcourseoftricuspidregurgitationandprognosticimplications
AT bramlagekarin naturalcourseoftricuspidregurgitationandprognosticimplications
AT bramlagepeter naturalcourseoftricuspidregurgitationandprognosticimplications
AT haasefielitzanja naturalcourseoftricuspidregurgitationandprognosticimplications
AT butterchristian naturalcourseoftricuspidregurgitationandprognosticimplications